Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo
Sponsored by King Saud University
About this trial
Last updated 15 years ago
Study ID
GB-NBVUB
Status
Unknown status
Type
Observational
Placebo
No
Accepting
12 to 65 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 14 years ago
What is this trial about?
Vitiligo is a common chronic skin disease with 1-4% prevalence. It has a significant
psychosocial impact on patients and society. Different treatment modalities with variable
success rates are available.
Phototherapy is among the successful treatments but gives modest results. Some reports
documented the usefulness of Ginkgo Biloba (GB) when used alone in Vitiligo treatment.
What are the participation requirements?
Inclusion Criteria
- Any Vitiligo patient (age 12 years and above) with non-segmental Vitiligo.
- Body surface area (BSA) involvement ≥ 3%.
Exclusion Criteria
- Unable to consent
- Any topical, systemic or phototherapy for Vitiligo in the previous 2 months.
- Pregnancy, breast feeding.
- Liver or kidney disease.
- Epilepsy
- Bleeding disorder or anticoagulant treatment
Locations
Location
Status
Recruiting